You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

177Lu-FAP-2286

Showing 1 - 25 of 275
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in United States (68Ga-FAP-2286, 177Lu-FAP-2286)

Recruiting
  • Solid Tumor
  • Birmingham, Alabama
  • +5 more
Aug 26, 2022

Solid Tumor, Unspecified, Adult Trial in Singapore (177Lu-LNC1004 Injection group 1 radionuclide therapy, 177Lu-LNC1004

Not yet recruiting
  • Solid Tumor, Unspecified, Adult
  • 177Lu-LNC1004 Injection group 1 radionuclide therapy
  • +3 more
  • Singapore, Singapore
    National University Cancer Institute, Singapore National Univers
Feb 1, 2023

177Lu-EB-FAPI Trial in Beijing (68Ga-FAPI for PET / CT scan and 177Lu-EB-FAPI for therapy)

Recruiting
  • 177Lu-EB-FAPI
  • 68Ga-FAPI for PET / CT scan and 177Lu-EB-FAPI for therapy
  • Beijing, Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
May 27, 2022

Solid Tumors, Adult, Metastatic Cancer Trial in San Francisco (Gallium-68 labelled (68Ga-) FAP-2286, Positron Emission

Recruiting
  • Solid Tumors, Adult
  • Metastatic Cancer
  • Gallium-68 labelled (68Ga-) FAP-2286
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 1, 2022

Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Esophageal Cancer Trial in Toronto ([Ga-68]-PNT6555, [Lu-177]-PNT6555)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +4 more
  • Toronto, Ontario, Canada
    University Health Network - Princess Margaret Cancer Centre
Aug 16, 2022

Tumor, Solid, Positron-Emission Tomography Trial in Xiamen (18F-FDG)

Recruiting
  • Tumor, Solid
  • Positron-Emission Tomography
  • 18F-FDG
  • Xiamen, Fujian, China
    The First affiliated hospital of xiamen university
Aug 8, 2022

Liver Fibrosis, Pulmonary Fibrosis, Myocardial Fibrosis Trial in San Francisco (68Ga-FAP-2286, Positron Emission Tomography

Recruiting
  • Liver Fibrosis
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 5, 2022

Breast Cancer Trial in Beijing (Al18F-NOTA-FAPI-04 PET/CT scan)

Recruiting
  • Breast Cancer
  • Al18F-NOTA-FAPI-04 PET/CT scan
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 10, 2022

Ovarian Cancer Trial (68Ga-FAPi-46)

Not yet recruiting
  • Ovarian Cancer
  • (no location specified)
Jun 12, 2023

Gastric Cancer, Gastro Esophageal Junctional Cancer, Cancer Trial (68Ga-FAPi-46)

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • (no location specified)
Jun 12, 2023

Non-hodgkin Lymphoma Trial (CD38-SADA:177Lu-DOTA Complex)

Not yet recruiting
  • Non-hodgkin Lymphoma
  • CD38-SADA:177Lu-DOTA Complex
  • (no location specified)
Aug 15, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.1 GBq (30 mCi) of 177Lu-P17-087, 1.1 GBq (30 mCi) of

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • 1.1 GBq (30 mCi) of 177Lu-P17-087
  • 1.1 GBq (30 mCi) of 177Lu-P17-088
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 30, 2022

Advanced Pancreatic Cancer and Cholangiocarcinoma Trial in Hangzhou (PRRT with 177Lu-EB-FAPI)

Recruiting
  • Advanced Pancreatic Cancer and Cholangiocarcinoma
  • PRRT with 177Lu-EB-FAPI
  • Hangzhou, Zhejiang, China
    First Affiliated Hospital of Zhejiang University
Oct 10, 2023

Prostate Cancer Trial in Wuxi (177Lu-labeled NY108)

Recruiting
  • Prostate Cancer
  • 177Lu-labeled NY108
  • Wuxi, Jiangsu, China
    Affiliated Hospital of Jiangnan University
Apr 4, 2023

Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

Not yet recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • With Positive PSMA Expression at Tumor Sites
  • 177Lu-PSMA-1 (radiopharmaceutical)
  • (no location specified)
Sep 26, 2023

Prostatic Tumors, Castration-Resistant Trial in Darlinghurst, Pretoria (225^Ac-PSMA-617, 68^Ga-PSMA-11)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • 225^Ac-PSMA-617
  • 68^Ga-PSMA-11
  • Darlinghurst, Australia
  • +1 more
Nov 23, 2022

Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (225Ac-PSMA-R2, 68Ga-PSMA-R2)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • (no location specified)
Aug 8, 2023

Cancer Trial in Meldola, Cesena ([177Lu]Lu-PSMA I&T)

Not yet recruiting
  • Cancer
  • [177Lu]Lu-PSMA I&T
  • Meldola, Forlì, Italy
  • +1 more
May 10, 2023

Neuroendocrine Tumors Trial in Worldwide (Data collection)

Active, not recruiting
  • Neuroendocrine Tumors
  • Data collection
  • Melbourne, Australia
  • +6 more
Aug 11, 2022

Prostate Cancer Trial (AAA617)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
Mar 27, 2023

Neuroendocrine Tumors, Lung Neuroendocrine Tumor, Thymus Tumors Trial in France, Italy, Spain (177Lu-edotreotide, Everolimus)

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Bourdeaux, France
  • +24 more
Jun 23, 2023

Prostate Cancer Trial in Houston (177Lu rhPSMA-10.1, Degarelix)

Not yet recruiting
  • Prostate Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2023

Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended

Not yet recruiting
  • Cancer
  • +3 more
  • 177Lu-PSMA-I&T - escalating renal absorbed dose
  • 177Lu-PSMA-I&T - recommended phase 2 regime
  • (no location specified)
Jun 14, 2023

Tumor, Positron-Emission Tomography Trial in Fuzhou (68Ga-FAP-CHX)

Recruiting
  • Tumor
  • Positron-Emission Tomography
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Aug 17, 2022

Lupus Nephritis Trial in Shanghai (68Ga-FAPI-04 PET)

Recruiting
  • Lupus Nephritis
  • 68Ga-FAPI-04 PET
  • Shanghai, China
    Ruijin Hospital
May 4, 2023